Interactions of Helicobacter pylori CagA with Host Factors
幽门螺杆菌 CagA 与宿主因子的相互作用
基本信息
- 批准号:8503595
- 负责人:
- 金额:$ 23.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-07-15 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenocarcinomaAmino AcidsBacteriaBindingBiochemicalBioinformaticsBiologicalCarcinogensCell AdhesionCell physiologyCellsCellular biologyCollaborationsComplexCrystallizationCytotoxinDataDegradation PathwayDuodenal UlcerFishesGastric ulcerHelicobacterHelicobacter pyloriHumanImageInfectionIntegration Host FactorsLaboratoriesLengthLinkMalignant NeoplasmsMass Spectrum AnalysisMediatingMethodsMolecularN-terminalNatureOncogenicOutcomePTPN11 genePhosphoric Monoester HydrolasesPopulationPositioning AttributeProcessProductivityPropertyProtein KinaseProteinsProteolysisReportingResolutionRoleSignal TransductionStomachStructureTechniquesTumor Suppressor ProteinsType IV Secretion System PathwayUbiquitinUlcerVirulenceWorld Health OrganizationX-Ray CrystallographyYeastscancer riskcarcinogenesisinsightmalignant stomach neoplasmnovelpathogenresearch studyscreeningsuccesstumorigenesisyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Helicobacter pylori is a Gram negative, microaerophilic gastric pathogen that infects nearly 50% of the human population. It is the sole pathogen able to colonize the stomach, and has been closely linked to duodenal and gastric ulcers and adenocarcinomas. The bacterium has been listed as a Group 1 carcinogen by the World Health Organization. The CagA cytotoxin of H. pylori is translocated into host cells by a Type IV Secretion System, interacts with many cellular proteins, increases virulence, and is associated with an increased risk of cancer. CagA has been shown to manipulate many host cellular functions, including cytoskeletal function, cell- to-cell adhesion, and intracellular signl transduction. However, how CagA functions has remained mostly a mystery for nearly two decades. Preliminary data from our laboratory is changing this situation. We have determined high-resolution crystal structures of CagA bound to host targets, have identified stable, soluble subdomains of this large cytotoxin, and have identified novel host factors that interact with these
subdomains. This application proposes to perform biochemical, structural, and infection biological studies of these identified subdomains and their interactions with host factors. The specific aims are (1) to identify, biochemically and structurally characterize the CagA functional subdomains, and (2) to identify, biochemically and structurally characterize the CagA-host factor interactions. Expected outcomes include obtaining detailed crystal structures of CagA host factor interactions, biochemical characterization of the nature of these interactions, and the role
of the interactions in modulating host cell biology. Such data will greatly enhance our understanding of virulence, as well as Helicobacter driven carcinogenesis.
描述(由申请人提供):幽门螺杆菌是一种革兰氏阴性、嗜微气的胃病原体,感染近50%的人口。它是唯一能够在胃中定植的病原体,与十二指肠溃疡和胃溃疡以及腺癌密切相关。这种细菌已被世界卫生组织列为1类致癌物。幽门螺杆菌的CagA细胞毒素通过IV型分泌系统转运到宿主细胞中,与许多细胞蛋白相互作用,增加毒力,并与癌症风险增加有关。CagA已被证明操纵许多宿主细胞功能,包括细胞骨架功能、细胞间粘附和细胞内信号转导。然而,近二十年来,CagA的功能一直是一个谜。我们实验室的初步数据正在改变这种情况。我们已经确定了与宿主靶点结合的CagA的高分辨率晶体结构,已经确定了这种大型细胞毒素的稳定,可溶的亚结构域,并且已经确定了与这些相互作用的新宿主因子
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles Erec Stebbins其他文献
Charles Erec Stebbins的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles Erec Stebbins', 18)}}的其他基金
Interactions of Helicobacter pylori CagA with Host Factors
幽门螺杆菌 CagA 与宿主因子的相互作用
- 批准号:
8352946 - 财政年份:2012
- 资助金额:
$ 23.9万 - 项目类别:
Assembly and Function of the Bacterial Type III Secretion System Basal Body
细菌III型分泌系统基体的组装和功能
- 批准号:
8535920 - 财政年份:2012
- 资助金额:
$ 23.9万 - 项目类别:
H PYLORI CAGA INHIBITS PAR1-MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
H PYLORI CAGA 通过模仿宿主底物抑制 PAR1 标记家族激酶
- 批准号:
8361570 - 财政年份:2011
- 资助金额:
$ 23.9万 - 项目类别:
STRUCTURAL CHARACTERIZATION OF THE TYPE 3 SECRETION SYSTEM
3 型分泌系统的结构特征
- 批准号:
8361578 - 财政年份:2011
- 资助金额:
$ 23.9万 - 项目类别:
H PYLORI CAGA INHIBITS PAR1-MARK FAMILY KINASES BY MIMICKING HOST SUBSTRATES
H PYLORI CAGA 通过模仿宿主底物抑制 PAR1 标记家族激酶
- 批准号:
8169199 - 财政年份:2010
- 资助金额:
$ 23.9万 - 项目类别:
Exploiting a Bacterial Nano-Syringe for Protein Therapeutics
利用细菌纳米注射器进行蛋白质治疗
- 批准号:
7886773 - 财政年份:2008
- 资助金额:
$ 23.9万 - 项目类别:
Exploiting a Bacterial Nano-Syringe for Protein Therapeutics
利用细菌纳米注射器进行蛋白质治疗
- 批准号:
7515332 - 财政年份:2008
- 资助金额:
$ 23.9万 - 项目类别:
Exploiting a Bacterial Nano-Syringe for Protein Therapeutics
利用细菌纳米注射器进行蛋白质治疗
- 批准号:
7656802 - 财政年份:2008
- 资助金额:
$ 23.9万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 23.9万 - 项目类别:














{{item.name}}会员




